In brief
The UK Health Security Agency announced a new study to assess exposure to persistent per‑ and polyfluoroalkyl substances—commonly called ”forever chemicals”—and heavy metals such as lead and arsenic in national blood and urine samples. Preliminary findings will be released in 2027, and early evidence suggests limited health effects but possible links to raised cholesterol and lower birth weight. The agency collaborates with international partners and currently does not recommend routine PFAS testing.
In a move that tackles one of the world’s most stubborn environmental toxins, the United Kingdom Health Security Agency (UKHSA) announced on Monday that it will launch a comprehensive study to assess exposure to per‑and polyfluoroalkyl substances (PFAS), the chemicals often dubbed "forever chemicals", alongside the heavy metals lead and arsenic. The study will mine blood and urine samples collected through an existing national health survey to gauge how deeply these substances have infiltrated the population. Preliminary findings from the analysis will be published in 2027. The initiative comes amid mounting international concern about the persistence and potential health impacts of PFAS, alongside a recognition that exposure to heavy metals remains a public‑health issue in many societies.
The initiative is described by Xinhua as a “major study” designed to ascertain population‑wide concentrations of PFAS, lead and arsenic in both blood and urine specimens. It draws on data from the Health Survey for England—a long‑standing, nationwide program that routinely collects biological samples for routine health surveillance. By adding chemical analyses to the existing survey framework, UKHSA will be able to generate nationwide exposure profiles without the need for a new set of field work, thereby reducing costs and speed‑to‑results.
• The study will measure a variety of PFAS compounds that presently appear in industrial processes and in everyday consumer goods such as cookware, food packaging, textiles, and firefighting foams. That range of uses paints a picture of how ubiquitous these chemicals are in modern life.
• In parallel, lead and arsenic will be quantified. Both heavy metals are well known to accumulate in human tissue over a lifetime and to pose risks ranging from neurodevelopmental harm in children to chronic kidney disease in adults.
• The analytic approach will involve high‑resolution mass spectrometry and inductively coupled plasma mass spectrometry, standard techniques that provide the sensitivity needed to detect trace-level concentrations.
Understanding the Potential Health Implications
Dr Edward Wynne‑Evans, the UKHSA director of radiation, chemicals, climate and environmental hazards, gave the agency’s assessment of the current evidence. He said that “the evidence available to date suggests that any health effects are likely to be limited.” The agency highlighted that the strongest evidence thus far points to possible associations with raised cholesterol and lower birth weight. He also stressed that further research is required to better comprehend these relationships and their long‑term implications.
"The evidence available to date suggests that any health effects are likely to be limited," said Dr Edward Wynne‑Evans. He added that the strongest evidence currently points to possible associations with raised cholesterol and lower birth weight.
The statement is consistent with the UKHSA’s own depiction of the existing literature. While some studies have linked PFAS exposure to adverse cardiovascular markers, the more definitive causal pathways remain debated. By contrast, the long‑established health literature surrounding lead describes clear neurotoxicity and developmental delays, whereas arsenic exposure is tied to both skin lesions and an increased risk of certain cancers.
UKHSA’s approach will also allow scientists to evaluate how PFAS, lead and arsenic concentrations vary across demographic groups—age, sex, ethnicity, and region—thereby highlighting which sections of society might be at higher risk. Such data will be crucial for future policy, whether it is to refine guidelines on permissible exposure levels or to target public‑health interventions.
International Collaboration and Policy Implications
According to the Xinhua report, the agency is collaborating with international partners to monitor emerging evidence and assess potential health risks. This cross‑border cooperation is vital, as PFAS are not restricted by national borders; their production, use and by‑products can travel globally through trade, atmospheric transport, and water runoff.
While the UKHSA presently does not recommend routine blood testing for PFAS, it stresses that further research will sharpen our understanding of what constitutes a “safe” blood concentration. Many nations have already implemented legislative measures to reduce PFAS manufacture and discharges; the UK’s forthcoming data will be instrumental in evaluating whether those regulations are keeping public exposure at acceptable levels. Moreover, the same data may inform future revisions to existing heavy‑metal guidelines.
The study will feed back into broader environmental and public‑health decisions. Environmental actions that reduce PFAS emissions—from regulating industrial processes to phasing out certain consumer products—could be prioritized if the data show significant exposure burdens. Likewise, the heavy‑metal analysis will either bolster or reconsider policies around mining, waste disposal, and water treatment.
As the UK sets up a comprehensive national exposure assessment, it joins a growing global list of countries that are recognizing the need to profile these persistent pollutants. The projected 2027 preliminary findings should provide fresh evidence on how the UK’s population compares to international averages, thereby offering a benchmark for neighboring countries in their pursuit of healthier, more sustainable communities.
"Britain’s approach to PFAS and heavy‑metal exposure surveillance is a critical step toward improving population health and aligning with the broader sustainability agenda,” said a spokesperson from the UKHSA, citing the agency’s role in the broader environmental and climate agenda. The data will not only inform local health recommendations but also help environmental scientists quantify turnover, sources, and the pathways that keep these chemicals in the food chain and the environment.
With the promise of 2027 preliminary results, the UKHSA’s study is poised to provide some of the first robust, nationally representative exposure data in the United Kingdom. The outlook is that these findings will shape interventions and policies that prevent future exposure, mitigate current risks, and safeguard the next generation from the lingering footprint of these chemicals.
